Search Results - Matthew S. Davids
- Showing 1 - 2 results of 2
-
1
Safety and efficacyof the combination of copanlisib and nivolumab in patients with Richter’s transformation or transformed non-Hodgkin lymphoma: results from a phase I trial by Geoffrey Shouse, Canping Chen, Alexandra Muir, Leslie Popplewell, Tanya Siddiqi, Jasmine Zain, Alex F. Herrera, Olga Danilova, Carly Roleder, Lili Wang, Stephen E.F. Spurgeon, Adam S. Kittai, Lu Chen, Zheng Xia, Matthew S. Davids, Alexey V. Danilov
Published 2025-07-01
Article -
2
The oral CDK9 inhibitor voruciclib combined with venetoclax for patients with relapsed/refractory acute myeloid leukemia by Yesid Alvarado-Valero, Rachel J. Cook, Shira N. Dinner, Michael Keng, Kebede H. Begna, Nathalie Javidi-Sharifi, Sameem Abedin, Monzr M. Al Malki, Vijaya Raj Bhatt, Prabhu Rajagopalan, Min Tang, Sandra E. Wiley, Richard G. Ghalie, Matthew S. Davids
Published 2025-08-01
Article